Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock SH
Symbol
PBH on NYSE
Shares outstanding
49,246,014
Price per share
$61.69
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
50,996,761
Total reported value
$3,183,717,332
% of total 13F portfolios
0%
Share change
-717,228
Value change
-$64,777,934
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
349
Price from insider filings
$60.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $636,203,831 7,524,587 BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 7.3% +56% $224,325,442 +$86,900,237 3,594,959 +63% Ariel Investments, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.9% $245,792,430 2,907,066 Dimensional Fund Advisors LP 31 Dec 2024
MACQUARIE GROUP LTD 4.7% $195,227,387 2,309,017 Macquarie Group Limited 31 Dec 2024
As of 30 Sep 2025, Prestige Consumer Healthcare Inc. - Common Stock SH (PBH) has 349 institutional shareholders filing 13F forms. They hold 50,996,761 shares. .

Top 25 institutional shareholders own 79% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 7,593,299 -4.7% 0.01% $473,821,839
VANGUARD GROUP INC 11% 5,492,748 -2.5% 0.01% $342,747,476
ARIEL INVESTMENTS, LLC 7.3% 3,594,959 +63% 2.4% $224,325,442
DIMENSIONAL FUND ADVISORS LP 5.3% 2,591,744 +4.8% 0.03% $161,722,895
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.5% 2,213,889 +27% 0.34% $138,146,674
STATE STREET CORP 4% 1,964,776 -1.7% 0% $122,602,022
MACQUARIE GROUP LTD 3.3% 1,620,912 -18% 0.12% $101,145,000
Allspring Global Investments Holdings, LLC 3.2% 1,592,375 +4.6% 0.16% $100,892,880
GEODE CAPITAL MANAGEMENT, LLC 2.9% 1,437,433 +1.7% 0.01% $89,706,434
WESTWOOD HOLDINGS GROUP INC 2.3% 1,141,817 +29% 0.51% $71,249,000
MORGAN STANLEY 2.3% 1,131,849 +5.8% 0% $70,627,421
Boston Trust Walden Corp 1.6% 786,086 -1.8% 0.36% $49,051,766
NORTHERN TRUST CORP 1.5% 747,706 +1% 0.01% $46,656,855
FMR LLC 1.5% 733,504 -1.6% 0% $45,770,680
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 703,528 -0.64% 0.01% $43,900,147
GOLDMAN SACHS GROUP INC 1.3% 639,810 -39% 0.01% $39,924,144
RAYMOND JAMES FINANCIAL INC 1.3% 637,932 +16% 0.01% $39,806,955
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1.3% 624,930 +13% 0.03% $38,995,632
BANK OF AMERICA CORP /DE/ 1.2% 615,414 -15% 0% $38,401,803
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.2% 590,297 -6.7% 0.01% $36,834,532
PRICE T ROWE ASSOCIATES INC /MD/ 1.1% 547,865 +3.1% 0% $34,188,000
Invesco Ltd. 1.1% 543,071 -57% 0.01% $33,887,631
D. E. Shaw & Co., Inc. 1.1% 538,025 +88% 0.03% $33,572,760
RICE HALL JAMES & ASSOCIATES, LLC 1% 509,668 -5.6% 1.7% $31,803,283
JPMORGAN CHASE & CO 0.93% 459,228 +30% 0% $28,655,827

Institutional Holders of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 1,083,674 $66,729,074 +$33,516,937 6,169% 10
2025 Q3 50,996,761 $3,183,717,332 -$64,777,934 6,240% 349
2025 Q2 52,028,281 $4,154,957,483 +$68,664,197 7,985% 373
2025 Q1 51,169,856 $4,398,239,758 -$95,059,471 8,597% 353
2024 Q4 52,462,477 $4,095,977,845 +$127,920,597 7,809% 334
2024 Q3 50,518,033 $3,645,571,766 -$31,949,506 7,210% 320
2024 Q2 51,045,564 $3,514,199,843 +$28,174,065 6,885% 303
2024 Q1 50,827,995 $3,687,233,175 -$34,968,923 7,256% 309
2023 Q4 129,416 $7,922,847 +$1,200,891 6,122% 2
2023 Q3 50,009,978 $2,860,447,178 +$57,448,860 5,719% 274
2023 Q2 48,906,531 $2,908,077,508 -$76,140,733 5,943% 269
2023 Q1 49,798,927 $3,118,541,878 +$46,888,220 6,263% 277
2022 Q4 49,414,418 $3,094,679,892 +$2,895,171 6,260% 282
2022 Q3 48,065,554 $2,395,969,471 -$25,170,290 4,982.97% 262
2022 Q2 50,551,252 $2,958,054,448 +$34,939,188 5,880.01% 271
2022 Q1 50,356,326 $2,667,329,806 -$38,061,389 5,293.98% 267
2021 Q4 50,526,704 $3,064,774,150 -$86,717,826 6,064.99% 259
2021 Q3 50,737,461 $2,847,437,009 -$66,712,696 5,610.99% 240
2021 Q2 51,938,628 $2,706,599,116 -$31,011,101 5,210% 220
2021 Q1 52,410,493 $2,310,208,512 +$9,580,120 4,407.99% 234
2020 Q4 52,115,008 $1,817,612,695 -$31,911,607 3,487.02% 223
2020 Q3 51,808,435 $1,884,600,046 -$68,927,967 3,641.95% 229
2020 Q2 54,953,672 $2,063,037,154 +$16,297,774 3,755.98% 245
2020 Q1 54,432,450 $1,997,117,882 -$229,857,918 3,667.98% 239
2019 Q4 60,113,311 $2,434,963,604 +$63,519,930 4,050.01% 221
2019 Q3 60,037,505 $2,082,494,275 -$40,711,457 3,468.98% 220
2019 Q2 61,694,668 $1,952,625,642 -$60,098,618 3,168% 200
2019 Q1 64,498,603 $1,929,222,460 +$1,578,153 2,990.99% 210
2018 Q4 61,989,087 $1,913,829,406 -$18,015,144 3,088% 222
2018 Q3 64,597,495 $2,447,613,220 +$43,756,348 3,788.99% 223
2018 Q2 63,463,749 $2,435,684,628 -$4,672,279 3,838% 223
2018 Q1 64,382,928 $2,170,729,154 +$69,131,096 3,371.98% 227
2017 Q4 60,466,869 $2,685,330,265 +$135,168,648 4,440.97% 241
2017 Q3 57,624,268 $2,884,851,451 +$206,604,271 5,009.01% 234
2017 Q2 53,342,117 $2,816,924,811 +$89,553,612 5,280.99% 225
2017 Q1 52,678,057 $2,926,935,219 +$403,573,241 5,555.98% 233
2016 Q4 51,459,515 $2,680,946,770 -$37,612,481 5,209.98% 229
2016 Q3 52,153,167 $2,514,952,408 -$16,356,192 4,826.98% 236
2016 Q2 52,441,370 $2,905,915,728 -$24,479,517 5,539.99% 261
2016 Q1 53,456,706 $2,858,226,135 +$45,734,163 5,338.99% 252
2015 Q4 53,091,100 $2,732,418,931 +$4,398,716 5,147.99% 231
2015 Q3 52,996,674 $2,393,384,785 -$9,216,670 4,515.99% 204
2015 Q2 52,710,303 $2,437,285,142 -$21,992,538 4,623.96% 203
2015 Q1 53,786,355 $2,306,271,997 -$37,476,164 4,289% 193
2014 Q4 55,190,237 $1,916,055,210 +$23,932,783 3,471.99% 175
2014 Q3 54,493,506 $1,763,985,461 +$44,771,507 3,236.98% 173
2014 Q2 52,483,144 $1,777,595,895 +$51,470,936 3,388.97% 181
2014 Q1 52,192,219 $1,422,261,770 +$11,843,262 2,724.99% 167